Plasma GluSph levels were higher in the GBA1 groups, regardless of PD status; other lipids such as the GCase substrate glucosylceramide, or GCase product ceramide, did not show any difference across groups [67]. This evidence concerns the gene GBA1 and Parkinson disease.